Literature DB >> 33141418

SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.

Pavithra Ayyanar1, Pritinanda Mishra1, Chappity Preetam2, Amit Kumar Adhya3.   

Abstract

SMARCB1/INI1 deficient sinonasal carcinoma is a variant of sinonasal undifferentiated carcinoma (SNUC). There is a paucity of literature describing the histomorphological features of this relatively new entity. Herein we describe the histomorphological features of three such cases and review the literature. We retrospectively reviewed the cases of SNUC diagnosed in our institute in the last 6 years. Immunohistochemistry for INI1, NUT & p16 were performed on these cases. Three cases showed loss of INI1. The histomorphology and clinicopathological features of these cases were studied and compared with non INI1 deficient SNUC. A total of 9 cases of SNUC were identified. Three of these cases showed loss of INI1. These three cases had presented with large sinonasal mass and with intracranial extension. Histopathology of these cases showed a diffuse infiltrative pattern, nest, and islands of predominantly basaloid cells with focal rhabdoid morphology. Additional features like small cell carcinoma like pattern, pseudoalveolar and pseudoglandular patterns, clear vacuoles and pseudopapillary appearance were also noted. We conclude that in presence of a mixed pattern of cells with a predominance of basaloid morphology, the possibility of SMARCB1/INI1 deficient sinonasal carcinoma must be strongly suspected and immunohistochemistry for INI1 must be performed.

Entities:  

Keywords:  Basaloid morphology; Rhabdoid morphology; SMARCB1/INI1 deficient sinonasal carcinoma; Sinonasal undifferentiated carcinoma; p16

Mesh:

Substances:

Year:  2020        PMID: 33141418      PMCID: PMC8134582          DOI: 10.1007/s12105-020-01246-9

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  19 in total

1.  Imaging Appearance of SMARCB1 (INI1)-Deficient Sinonasal Carcinoma: A Newly Described Sinonasal Malignancy.

Authors:  D R Shatzkes; L E Ginsberg; M Wong; A H Aiken; B F Branstetter; M A Michel; N Aygun
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-07       Impact factor: 3.825

2.  Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV).

Authors:  Beth Wadsworth; Jeffery M Bumpous; Alvin W Martin; Michael R Nowacki; Alfred B Jenson; Hanan Farghaly
Journal:  Head Neck Pathol       Date:  2011-07-30

3.  SMARCA4-deficient Sinonasal Carcinoma.

Authors:  Abbas Agaimy; Wilko Weichert
Journal:  Head Neck Pathol       Date:  2017-02-07

4.  A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.

Authors:  Isabella Versteege; Souhila Medjkane; Danny Rouillard; Olivier Delattre
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

5.  Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.

Authors:  Bryan L Betz; Matthew W Strobeck; David N Reisman; Erik S Knudsen; Bernard E Weissman
Journal:  Oncogene       Date:  2002-08-08       Impact factor: 9.867

6.  SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.

Authors:  Justin A Bishop; Cristina R Antonescu; William H Westra
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

7.  NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.

Authors:  Edward B Stelow; Andrew M Bellizzi; Krishan Taneja; Stacey E Mills; Robin D Legallo; Jeffery L Kutok; Jon C Aster; Christopher A French
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

8.  SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.

Authors:  Vanessa Trieu; Ricardo Mario Aulet; Allison Ciolino; Tamara Rimash
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-03-15       Impact factor: 1.547

9.  SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.

Authors:  Abbas Agaimy; Michael Koch; Michael Lell; Sabine Semrau; Wojciech Dudek; David L Wachter; Antje Knöll; Heinrich Iro; Florian Haller; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

Review 10.  Oncogenic roles of SMARCB1/INI1 and its deficient tumors.

Authors:  Kenichi Kohashi; Yoshinao Oda
Journal:  Cancer Sci       Date:  2017-04-12       Impact factor: 6.716

View more
  3 in total

1.  Commentary on: SMARCB1 as a novel diagnostic and prognostic biomarker for osteosarcoma.

Authors:  Consolato M Sergi
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

Review 2.  SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes.

Authors:  Victor Ho-Fun Lee; Raymond King-Yin Tsang; Anthony Wing Ip Lo; Sum-Yin Chan; Joseph Chun-Kit Chung; Chi-Chung Tong; To-Wai Leung; Dora Lai-Wan Kwong
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

3.  Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.